Society of Neuroimmune Pharmacology Inc

Nonprofit profile at a glance

EIN
582586479
IRS 990-EZ coverage
2012–2025
Forms available
Form 990 2019, Form 990-EZ 2025, Form 990-N 2021
Location
Gainesville, FL, USA
Phone
3522945275
Rating confidence
Limited
Sector
Nerve, Muscle and Bone Diseases

Official website

Reported finances

Revenue
$75,825
Expenses
$128,195
Assets
$67,871
Liabilities
$0

Source: IRS Form 990-EZ. Selected filing: tax year 2025. Amounts in USD.

Leadership & pay

12 people listed

People named in this filing

  • Sabita Roy (Meeting Chair (Thru 6/25))
  • Ilker K Sariyer - Chair (Communications (Thru 6/25))
  • Andrea D Raymond (Chair, DISC Committee (Thru 6/25))

Selected names, not a complete roster or a statement of current roles. Open leadership details for the complete filed list.

Source: IRS Form 990-EZ. Selected filing: tax year 2025. Names and roles reflect this filing, not necessarily current officeholders.

Overview

Mission

The mission of the SNIP is to: promote research and serve as a reliable source of information in the pharmacology, immunology, and neuroscience of the neuroimmune axis; foster exchange of information and ideas on neuroimmune pharmacology by holding an annual SNIP Conference, maintaining a Society web site (s-nip.org), and supporting and promoting the Society journal, the Journal of Neuroimmune Pharmacology (JNIP); encourage financial support from funding agencies, industry, and the SNIP membership to effect the SNIP mission.

What it reported doing in 2025

The society sponsored a conference for attendees to present scientific research which includes new data, trends in the field and novel technology related to the area of Neuroimmune Pharmacology. The conference was attended by approximately 210 scientists of all career stages (students, staff, and professors). The society sponsors students and post-doctoral fellows to attend the annual conference.

Operating model

Revenue model
Earned-program. 93% of the money available for current operations came from fees and other program revenue.
Distribution model
Cannot be determined from the filing. The filing does not provide enough consistent spending detail to tell whether the nonprofit works directly or through others.

The verdict

- The available evidence is not sufficient to produce an overall rating for this filing. This is not a warning sign.

Rating breakdown

  • Financial Efficiency: NotEnoughData
  • Transparency & Controls: 100
  • Sustainability: 29
  • Growth: 0

Detailed rating inputs

Financial Efficiency

  • Mission deployment rate: Limited
  • Program expense ratio: Limited

Transparency & Controls

  • Consistency checks: 100%; rating input score 100; 51st percentile among comparable filings
  • Major donor itemization: Yes; rating input score 100

Sustainability

  • Operating margin: -69.1%; rating input score 10; 10th percentile among comparable filings
  • Total-asset coverage ratio: 0.53; rating input score 33; 33rd percentile among comparable filings
  • Liabilities to assets ratio: 0; rating input score 66; 66th percentile among comparable filings
  • Officer compensation ratio: 0%; rating input score 56; 56th percentile among comparable filings

Growth

  • Program expense growth: -2.6% per year; rating input score 0; 41st percentile among comparable filings
  • Revenue growth: -4.7% per year; rating input score 0; 35th percentile among comparable filings
  • Asset growth: -3.2% per year; rating input score 0; 28th percentile among comparable filings

Details

  • Where the money goes: Financial trends and filed revenue, expense, asset, and liability detail
  • Governance: Filed governance answers
  • Accomplishments: 1 filed program accomplishment
  • Leadership: top reported pay $0 · 12 people listed
  • Consistency: 7 of 7 current checks pass
  • Schedules: 3 filed schedules
  • Filing history: 12 filing years from 2012 to 2025
  • Contacts: How to reach this organization
  • Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
  • People: Everyone the filings name, and which of them the filings identify by more than a name.

Key Signals

Signals prioritize questions for review. They are not findings of misconduct.

  • High — Sustainability: Operating margin scored 10/100.
  • High — Growth: Program expense growth scored 0/100.
  • High — Growth: Revenue growth scored 0/100.
  • High — Growth: Asset growth scored 0/100.
  • Moderate — Sustainability: Total-asset coverage ratio scored 33/100.
  • Review — Sustainability: Officer compensation ratio scored 56/100.